Lerozol 2.5
- Letrozole: A potent aromatase inhibitor for hormone receptor positive breast cancer.
- Effective in early and advanced stages, especially in postmenopausal women.
- Reduces estrogen levels, hindering growth of estrogen-dependent cancer cells.
- Administered as adjunctive or first-line therapy with a daily 2.5 mg dose.
- Contraindicated during pregnancy and lactation; caution in hepatic dysfunction.